Singapore: GlaxoSmithKline (GSK) has received approval from the US FDA for Flulaval Quadrivalent (influenza virus vaccin...
Singapore: The US NIH announced that it is all set to launch an early-stage clinical trial of an experimental vaccine ag...
Singapore: China-based Simcere Pharmaceutical clocked $85.1 million revenue for the first quarter of 2013, representing ...
Singapore: Taiwan-based Adimmune has highlighted that it can begin supplying vaccines against the current strain of H7N9...
Singapore: The Vaccines Industry Association of New Zealand (VIANZ) has merged with the industry body Medicines New Zeal...
Singapore: US-based PaxVax, a specialty vaccine company, has confirmed positive efficacy results from 90-day challenge s...
Singapore: Transgene's Chinese 50:50 equity joint venture with Tasly Pharmaceutical has started its operations. The join...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement with Th...
Bangalore: The GAVI Alliance signed a supply agreement with Biological E, India, according to which it will receive the ...
Singapore: Even as a new strain of stomach flu is infecting many across the world, scientists in Japan seem to have made...
Singapore: Concluding an elaborate probe that started late last year, China has now said that the hepatitis B vaccines w...
Singapore: The Shimadzu Global Pharma Summit 2012 held in Singapore sent out an unaninmous message that it is high time ...
Singapore: Sinovac Biotech, a provider of vaccines in China, reported preliminary top-line data from its phase III clin...
Singapore: The annual cases of cholera in the Caribbean Islands was reduced by 75 percent in the first quarter of 2014, ...
"Where the mind is without fear and the head is held very high." This famous quote of Nobel winning poet Rabindranath Ta...
Single-use technologies are a particularly smart way of manufacturing vaccines during a pandemic, when there is urgency ...
Singapore: The US Food and Drug Administration's (FDA's) Vaccines and Related Biological Products Advisory Committee vot...
A year after India released its National Vaccine Policy, industry experts say it is time to draw up a plan to put the gu...
